Alexanderson, B., and Sjöqvist, F. (1971). Individual differences in the pharmacokinetics of monomethylated tri-cyclic antidepressants: role of the genetic and environmental factors and clinical importance. Annals of the New York Academy of Sciences, 179, 739–751.
Angrist, B. M., Shopsin, B., and Gershon, S. (1971). The comparative psychotomimetic effects of stereoisomers of amphetamine. Nature, 234, 152–153.
Angst, J. (1964). Antidepressiver Effekt and genetische Faktoren. Arzneimittelforschung, 14, Suppl. 496–500.
Cohen, S. N., and Weber, W. W. (1972). Pharmacogenetics. Pediatric Clinics of North America, 19, 21–36.
Evans, D. A. P. (1969). Pharmacogenetics. In Selected Topics in Medical Genetics, pp. 69–109. Edited by Clarke, C. A.. Oxford University Press: London.
Evans, D. A. P., Davison, K., and Pratt, R. T. C. (1965). The influence of acetylator phenotype on the effects of treating depression with phenelzine. Clinical Pharmacology and Therapeutics, 6, 430–435.
Fenna, D., Mix, L., Schaefer, O., and Gilbert, J. A. L. (1971). Ethanol metabolism in various racial groups. Canadian Medical Association Journal, 105, 472–475.
Gershon, E. S., Dunner, D. L., and Goodwin, F. K. (1971). Toward a biology of affective disorders. Genetic contributions. Archives of General Psychiatry, 25, 1–15.
Harris, T. H. (1957). Depression induced by Rauwolfia compounds. American Journal of Psychiatry, 113, 950.
Hollister, L. E. (1970). Choice of antipsychotic drugs. American Journal of Psychiatry, 127, 186–190.
Horn, A. S., and Snyder, S. H. (1971). Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proceedings of the National Academy of Sciences, 68, 2325–2328.
Johnstone, E. C., and Marsh, W. (1973). Acetylator status and response to phenelzine in depressed patients. Lancet, 1, 567–570.
Jones, K. L., Smith, D. W., Ulleland, C. N., and Streissguth, A. P. (1973). Pattern of malformation in offspring of chronic alcoholic mothers. Lancet, 1, 1267–1271.
Kalow, W. (1962). Pharmacogenetics: Heredity and the Response to Drugs. Saunders: Philadelphia.
Klawans, H. L. Jr, Paulson, G. W., Ringel, S. P., and Barbeau, A. (1972). Use of L-dopa in the detection of pre-symptomatic Huntington's chorea. New England Journal of Medicine, 286, 1332–1334.
Kutt, H. (1971). Biochemical and genetic factors regulating Dilantin metabolism in man. Annals of the New York Academy of Sciences, 179, 705–722.
Morrow, A. C., and Motulsky, A. G. (1968). Rapid screening method for the common atypical pseudocholinesterase variant. Journal of Laboratory and Clinical Medicine, 71, 350–356.
Motulsky, A. G. (1972). Hemolysis in glucose-6-phosphate dehydrogenase deficiency. Federation Proceedings, 31, 1286–1292.
Motulsky, A. G. (1964). Pharmacogenetics. Progress in Medical Genetics, 3, 49–74.
Musacchio, J. M., Julou, L., Kety, S. S., and Glowinski, S. S. (1969). Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proceedings of the National Academy of Sciences, 63, 1117–1119.
Myrianthopoulos, N. C., Waldrop, F. N., and Vincent, B. L. (1969). A repeat study of hereditary predisposition in drug-induced parkinsonism. In Progress in Neuro-Genetics. Edited by Barbeau, A. and Brunette, J.-R.. Excerpta Medica: Amsterdam. International Congress Series No. 175, 486–491.
Omenn, G. S. (1973a). Genetic issues in the syndrome of minimal brain dysfunction. Seminars in Psychiatry, 5, 5–17.
Omenn, G. S. (1973b). A pharmacogenetic approach to depression, in Bruell, J. (ed.), Prospects in Behavior Genetics. Russell Sage Foundation: New York. (In press.)
Omenn, G. S., and Motulsky, A. G. (1972). A biochemical and genetic approach to alcoholism. Annals of the New York Academy of Sciences, 197, 16–23.
Omenn, G. S., and Motulsky, A. G. (1973). Pharmacogenetics. Year Book of Drug Therapy, 1973, pp. 5–26. Year Book Medical Publishers: Chicago.
Pare, C. M. B., and Mack, J. W. (1971). Differentiation of two ganetically specific types of depression by the response to antidepressant drugs. Journal of Medical Genetics, 8, 306–309.
Pare, C. M. B., Rees, L., and Sainsbury, M. J. (1962). Differentiation of two genetically specific types of depression by the response to anti-depressants. Lancet, 2, 1340–1343.
Rosenthal, D. (1970). Genetic Theory and Abnormal Behavior, pp. 92–200. McGraw-Hill: New York.
Schildkraut, J. J. (1969). Neuropsychopharmacology and the affective disorders. New England Journal of Medicine, 281, 197–201, 248–255, 302–308.
Schuckit, M. A. (1972). Family history and half-sibling research in alcoholism. Annals of the New York Academy of Sciences, 197, 121–125.
Snyder, S. H., Taylor, K. M., Coyle, J. T., and Meyerhoff, J. L. (1970). The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. American Journal of Psychiatry, 127, 199–207.
Vesell, E. S., Page, J. G., and Passananti, G. T. (1971). Genetic and environmental factors affecting ethanol metabolism in man. Clinical Pharmacology and Therapeutics, 12, 192–201.
Vogel, F. (1970). The genetic basis of the normal human electroencephalogram (EEG). Humangenetik, 10, 91–114.
Watson, C. J., Dhar, G. J., Bossenmaier, I., Cardinal, R., and Petryka, Z. J. (1973). Effect of hematin in acute porphyric relapse. Annals of Internal Medicine, 79, 80–83.
Williams, R. J. (1956). Biochemical Individuality. Wiley: New York.
Wolff, P. H. (1972). Ethnic differences in alcohol sensitivity. Science, 175, 449–450.